SCHEMBL24101508

SCHEMBL24101508

CN(C)[C@H]1Cc2[nH]c3cnccc3c2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 8/20 0.39
KDM4E B2RXH2 1/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
IKBKB O14920 1/20 0.39
AURKA O14965 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PIM1 P11309 1/20 0.39
TOP1 P11387 1/20 0.39
GABRA1 P14867 1/20 0.39
IDO1 P14902 1/20 0.39
HPGD P15428 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24101496 1.00 CHUK (0.39) CHUKKDM4EGABRPGABRDIKBKB
SCHEMBL24101514 0.88 ACHE (0.39) CHUKKDM4EGABRPGABRDIKBKB
SCHEMBL24101503 0.88 ACHE (0.39) CHUKKDM4EGABRPGABRDIKBKB
SCHEMBL25847146 0.87 HTR1F (0.45) CHUKKDM4EGABRPGABRDIKBKB
SCHEMBL24101523 0.87 HTR1F (0.45) CHUKKDM4EGABRPGABRDIKBKB
SCHEMBL24101511 0.87 HTR1F (0.45) CHUKKDM4EGABRPGABRDIKBKB
SCHEMBL24101500 0.85 HTR1D (0.40) CHUKKDM4EGABRPGABRDIKBKB
SCHEMBL24101498 0.85 HTR1D (0.40) CHUKKDM4EGABRPGABRDIKBKB
SCHEMBL24101860 0.85 HTR1D (0.40) CHUKKDM4EGABRPGABRDIKBKB
SCHEMBL24101538 0.76 HTR1F (0.47) HPGDHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227453-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-20 US disclosed
US-20230227453-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-20 US disclosed
WO-2021252691-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227453-A1 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF GAP43, GRIN2A, GRIN2C CHUK 4310/4885KDM4E 2586/4885GABRP 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.